Insulin Pens Market to 2027 - Global Analysis and Forecasts by Product Type, Application, Distribution Channel and Geography.
The global insulin pens market is expected to reach US$ 8,862.0 Mn in 2027 from US$ 4,199.7 in 2018. The market is estimated to grow with a CAGR of 8.8% from 2019-2027.
The key factors that are driving the growth of the market are rising incidence of diabetes, growing geriatric population, and increasing adoption of insulin pens over conventional vials and syringes. However, the factors restraining the market growth are high cost of insulin pens and the availability of alternatives to insulin pens in the market. On the other hand, the high potential for market growth in emerging economies is one of the growth opportunities for market players.
In recent years, there has been considerable development in the field of medical drug delivery devices. Insulin administration is a standard procedure in the diabetic population. Traditional insulin syringes have several disadvantages that include the experience of pain by patients due to repeated pricks, discomfort in carrying both insulin bottle as well as a syringe, risk of needle re-use associated infections and needle-stick injuries as well as difficulty in delivering a mixture of two or more liquids together in one syringe. Additionally, self-administration of insulin through syringes and vials is time-taking and difficult that has reduced the adoption of conventional insulin injection methods over the past years and led to increased adoption of injection pens. Thus, the inclination of patients towards insulin injection pens over syringes is expected to be a driving factor to foster the growth of insulin pens market.
Global insulin pens market was segmented by product type, application, and end user. The insulin pens market on the basis of product type is segmented in to disposable and reusable. In 2018, the reusable segment held the largest share of the market, by product type. Moreover, the smart insulin pen caps segment of insulin pens market is expected to witness growth in its demand at a fastest CAGR of 9.9% during 2019 to 2027. Various start-ups and established manufacturers are coming up with the concepts of smart insulin pen caps that turns conventional pen injectors into connected devices that helps to capture treatment information such as date, dose and time of the injection. The ability of these devices to convert traditional pens into technologically advanced injection pens are expected to account for the growth of the segment in the global insulin pens market.
Some of the major primary and secondary sources included in the report for the insulin pens market are World Health Organization, American Diabetes Association, National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes UK, Centers for Disease Control and Prevention, Chinese Diabetes Society, International Diabetes Federation, and others.
Reasons to Buy
The global insulin pens market is expected to reach US$ 8,862.0 Mn in 2027 from US$ 4,199.7 in 2018. The market is estimated to grow with a CAGR of 8.8% from 2019-2027.
The key factors that are driving the growth of the market are rising incidence of diabetes, growing geriatric population, and increasing adoption of insulin pens over conventional vials and syringes. However, the factors restraining the market growth are high cost of insulin pens and the availability of alternatives to insulin pens in the market. On the other hand, the high potential for market growth in emerging economies is one of the growth opportunities for market players.
In recent years, there has been considerable development in the field of medical drug delivery devices. Insulin administration is a standard procedure in the diabetic population. Traditional insulin syringes have several disadvantages that include the experience of pain by patients due to repeated pricks, discomfort in carrying both insulin bottle as well as a syringe, risk of needle re-use associated infections and needle-stick injuries as well as difficulty in delivering a mixture of two or more liquids together in one syringe. Additionally, self-administration of insulin through syringes and vials is time-taking and difficult that has reduced the adoption of conventional insulin injection methods over the past years and led to increased adoption of injection pens. Thus, the inclination of patients towards insulin injection pens over syringes is expected to be a driving factor to foster the growth of insulin pens market.
Global insulin pens market was segmented by product type, application, and end user. The insulin pens market on the basis of product type is segmented in to disposable and reusable. In 2018, the reusable segment held the largest share of the market, by product type. Moreover, the smart insulin pen caps segment of insulin pens market is expected to witness growth in its demand at a fastest CAGR of 9.9% during 2019 to 2027. Various start-ups and established manufacturers are coming up with the concepts of smart insulin pen caps that turns conventional pen injectors into connected devices that helps to capture treatment information such as date, dose and time of the injection. The ability of these devices to convert traditional pens into technologically advanced injection pens are expected to account for the growth of the segment in the global insulin pens market.
Some of the major primary and secondary sources included in the report for the insulin pens market are World Health Organization, American Diabetes Association, National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes UK, Centers for Disease Control and Prevention, Chinese Diabetes Society, International Diabetes Federation, and others.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the insulin pens market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global insulin pens market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Global Insulin Pens- Market Landscape
5. Insulin Pens Market - Key Market Dynamics
6. Insulin Pens Market - Global Analysis
7. Global Insulin Pens Market Analysis And Forecasts To 2027 - Product Type
8. Global Insulin Pens Market Analysis And Forecasts To 2027 - Application
9. Global Insulin Pens Market Analysis- By Distribution Channel
10. Insulin Pens Market Revenue And Forecasts To 2027 - Geographical Analysis
11. Insulin Pens Market - Industry Landscape
12. Insulin Pens Market-Key Company Profiles
13. Appendix
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Novo Nordisk A/S
- Owen Mumford
- Sanofi
- Ypsomed AG
- Biocon
- Companion Medical
- BERLIN CHEMIE AG
- Eli Lilly and Company
- Pendiq GmbH
- Emperra GmbH E-Health Technologies